Economist Events and Ipsen are organising a webinar entitled “Leaving the darkness: Tackling rare bone diseases” featuring the participation of clinical specialists, health policy experts and patient groups. The webinar will take place on September 22, 2021 from 17.00 – 18.00 CET. The webinar will discuss the complex context of rare bone diseases and how care can be re-oriented to…
EuropaBio continues its Advanced Therapies webinar series of events, interviews, and publications with a virtual discussion on avenues for enhancing the access of EU patients to novel biotechnology-derived treatments titled “Treatment without borders: the EU case for equitable patient access to advanced therapies.” The webinar will take place on September 7, 2021 from 16.00 – 17.00 CET. The event will address whether EU…
eureKARE, a company that invests in and supports European early-stage high-risk projects in the field of microbiome and synthetic biology has announced a competition between promising academic projects in synthetic biology across Europe. All European researchers (PhD, postdocs, senior researchers) are invited to participate to the competition. The winner of the competition will get free…
The Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen and the University of Cambridge’s Centre for Law, Medicine and Life Sciences (LML) are jointly organising the 2021 Annual Symposium on the theme of Orphan Drug Innovation: Needs and Priorities. The event is targeted towards legal,economic, business, medical, and scientific…
Innovative techniques in the biomedical field (such as massive sequencing capacity, gene editing and tissue engineering) have resulted in the development of new unconventional drugs in the Advanced Therapy Medicinal Products (ATMPs) class. In this scenario, the European Paediatric Translational Research Infrastructure (EPTRI) and the EU-funded RESTORE project are collaborating to describe the map of competences available in the framework of the paediatric ATMP research in pan-European…